As Losses Narrow, Is Zai Lab Finally Finding its Winning Formula?
The biotech breaks a cycle of widening losses as it shifts towards developing new drugs Key Takeaways: Zai Lab reported its loss shrank 65% in the first quarter of the…
RELATED ARTICLES
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK -
Everest reaches new heights on growing drug sales
1952.HK
- InSilico seeks IPO boost to get AI drugs over the line
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
FAST NEWS: Zai Lab’s loss narrows on strengthening sales
9688.HK ZLAB.US
